{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "marketState": "PRE", "exchange": "NCM", "regularMarketChangePercent": 0.0, "regularMarketPrice": 3.21, "firstTradeDateMilliseconds": 1009981800000, "priceHint": 4, "earningsTimestamp": 1677675602, "earningsTimestampStart": 1690806600, "earningsTimestampEnd": 1691152200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.25, "epsForward": -1.06, "epsCurrentYear": -0.95, "priceEpsCurrentYear": -3.3789475, "sharesOutstanding": 17403600, "bookValue": 9.9, "fiftyDayAverage": 3.12742, "fiftyDayAverageChange": 0.08258009, "fiftyDayAverageChangePercent": 0.026405182, "twoHundredDayAverage": 5.531, "twoHundredDayAverageChange": -2.321, "twoHundredDayAverageChangePercent": -0.4196348, "marketCap": 55865556, "forwardPE": -3.0283022, "priceToBook": 0.32424244, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-25", "averageAnalystRating": "1.7 - Buy", "tradeable": false, "cryptoTradeable": false, "shortName": "Portage Biotech Inc.", "longName": "Portage Biotech Inc.", "messageBoardId": "finmb_233586353", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChange": 0.0, "regularMarketTime": 1684180793, "regularMarketDayHigh": 3.3, "regularMarketDayRange": "3.01 - 3.3", "regularMarketDayLow": 3.01, "regularMarketVolume": 9771, "regularMarketPreviousClose": 3.21, "bid": 0.0, "ask": 0.0, "bidSize": 11, "askSize": 12, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 3.03, "averageDailyVolume3Month": 24925, "averageDailyVolume10Day": 24020, "fiftyTwoWeekLowChange": 0.8700001, "fiftyTwoWeekLowChangePercent": 0.37179494, "fiftyTwoWeekRange": "2.34 - 11.99", "fiftyTwoWeekHighChange": -8.78, "fiftyTwoWeekHighChangePercent": -0.7322769, "fiftyTwoWeekLow": 2.34, "fiftyTwoWeekHigh": 11.99, "dividendDate": 1591228800, "displayName": "Portage Biotech", "symbol": "PRTG"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Craigmuir Chambers", "address2": "Road Town", "city": "Tortola", "zip": "VG1110", "country": "British Virgin Islands", "website": "https://www.portagebiotech.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; TT-10, an adenosine receptor type 2A (A2A) inhibitor to treat A2A expressing solid tumors; TT-4, an adenosine receptor type 2B (A2B) inhibitor to treat solid tumors; TT-53, an A2A/A2B inhibitor to treat solid tumors; TT-3, an A2B inhibitor to treat colorectal and gastrointestinal cancers; and NT230-6 that is in Phase I/II clinical trials for the treatment of tumors. It also provides Nanolipogel (NLG) co-formulation platform for delivery of DNA aptamers and certain aptamer-small molecule-based combination products; and STING agonist platform, a proprietary immune priming and boosting technology, offers various ways to target immune stimulation towards the cancer, as well as to co-deliver various signals in a single product. The company is based in Tortola, British Virgin Islands.", "fullTimeEmployees": 6, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ian B. Walters M.B.A., M.D.", "age": 54, "title": "CEO & Chairman of Board", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 848147, "fmt": "848.15k", "longFmt": "848,147"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Allan J. Lee Shaw CPA", "age": 58, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 430952, "fmt": "430.95k", "longFmt": "430,952"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Steven  Innaimo", "title": "VP of Project Management & Operations", "fiscalYear": 2022, "totalPay": {"raw": 416952, "fmt": "416.95k", "longFmt": "416,952"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Robert A. Kramer Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2022, "totalPay": {"raw": 278501, "fmt": "278.5k", "longFmt": "278,501"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Brian  Wiley", "age": 54, "title": "Chief Bus. Officer", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 252171, "fmt": "252.17k", "longFmt": "252,171"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Joseph  Ciavarella", "title": "Chief Accounting Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}